CNR1 and Alzheimer disease: AD-relevant bioactivities encompass target enzymes (e.g., cholinesterases, monoamine oxidases, carbonic anhydrases), receptors (e.g., cannabinoid receptors 1 and 2), aggregation-prone peptides (e.g., β-amyloid), and the chelation of redox metal species.